Tue Dec 7, 2021 – 12:16 pm ESTTue Dec 7, 2021 – 12:18 pm EST
ANALYSIS
(LifeSiteNews) — President Joe Biden’s nominee to lead the FDA expanded the use of the abortion pill Mifeprex and has been a paid consultant to dozens of pharmaceutical companies, including COVID vaccine manufacturers Pfizer, Johnson & Johnson, and AstraZeneca.
“Dr. Robert Califf is one of the most experienced clinical trialists in the country, and has the experience and expertise to lead the Food and Drug Administration during a critical time in our nation’s fight to put an end to the coronavirus pandemic,” said the White House in a press release announcing the nomination.
The White House statement signals that Califf will be involved in approving more COVID vaccines and potentially other COVID treatments. Biden continued, “As the FDA considers many consequential decisions around vaccine approvals and more, it is mission critical that we have a steady, independent hand to guide the FDA. I am confident Dr. Califf will ensure that the FDA continues its science and data driven decision-making.”
If his appointment is approved by the Senate, this will not be Califf’s first time serving at the FDA. A professor of cardiology at Duke University and founder of its prestigious Duke Clinical Research Institute, Califf was previously appointed as Deputy Commissioner of the FDA in January 2015. Eight months later, he was nominated to lead the FDA by
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors